Biallelic mutations of the DNA annealing helicase SMARCAL1 (SWI/SNF-related, matrix-associated, actindependent regulator of chromatin, subfamily a-like 1) cause Schimke immuno-osseous dysplasia (SIOD, MIM 242900), an incompletely penetrant autosomal recessive disorder. Using human, Drosophila and mouse models, we show that the proteins encoded by SMARCAL1 orthologs localize to transcriptionally active chromatin and modulate gene expression. We also show that, as found in SIOD patients, deficiency of the SMARCAL1 orthologs alone is insufficient to cause disease in fruit flies and mice, although such deficiency causes modest diffuse alterations in gene expression. Rather, disease manifests when SMARCAL1 deficiency interacts with genetic and environmental factors that further alter gene expression. We conclude that the SMARCAL1 annealing helicase buffers fluctuations in gene expression and that alterations in gene expression contribute to the penetrance of SIOD. †
INTRODUCTION
With the discovery of incomplete penetrance in 1925 (1) (2) (3) , it became apparent that not all individuals with identical mutant alleles necessarily manifest a trait. Incomplete penetrance has been attributed to genetic and environmental factors as well as to developmental stochastics (4 -7) . In its strictest sense, incomplete penetrance applies to the entire lifetime of the individual (8) , although some traits initially considered incompletely penetrant are probably better described as having agedependent penetrance (8, 9) .
Incomplete penetrance for autosomal recessive disorders is less commonly described than for autosomal dominant disorders, but it does occur (4, (10) (11) (12) (13) . Examples of genetic and environmental modulators of incomplete penetrance in autosomal recessive disorders are illustrated by the following. The penetrance of the deafness phenotype in individuals with biallelic mutations of DFNB26 can be suppressed by a dominant allele of the DFNM1 locus (10) . The penetrance of Bardet -Biedl syndrome can require the triallelic inheritance of mutations compromising BBSome complex assembly and vesicle trafficking to the ciliary membrane (11, 14, 15) . In cystic fibrosis, the T7 polypyrimidine track variant in intron 8 of CFTR leads to more efficient splicing of exon 9 and reduces penetrance of the p.R117H mutation and cystic fibrosis to 0.03% for individuals with the compound heterozygous mutations p.[R117H; T7] + [DF508] (12, 16, 17) . Suppression of phenylketonuria in individuals with biallelic mutations of PAH is possible through restriction of dietary phenylalanine (18) . Lastly, the penetrance of hemochromatosis in individuals with biallelic mutations of HFE depends on a combination of genetic factors such as polymorphisms in iron metabolism genes and environmental factors affecting the iron load such as alcohol, dietary iron intake, age and gender (13, 19) . Despite this progress, however, the basis of incomplete penetrance remains undefined for most autosomal recessive disorders, including Schimke immuno-osseous dysplasia (SIOD).
Recently, two families have been reported in which siblings of affected individuals have incomplete penetrance of SIOD (20, 21) . SIOD is a multisystem disorder of renal failure, immunodeficiency, skeletal dysplasia, arteriosclerosis, migrainelike headaches, cerebral ischemia, bone marrow failure and hypothyroidism (22, 23) . It is associated with biallelic mutations in SMARCAL1 that cause loss of SMARCAL1 enzymatic function (24) (25) (26) . The SMARCAL1 enzyme recognizes single-stranded (ss)-to-double-stranded (ds) transitions in DNA (27) and functions as an annealing helicase (26) . It also serves as a DNA stress response protein that participates in the maintenance of genomic integrity at stalled replication forks (28) (29) (30) (31) (32) . Since components of DNA repair pathways frequently participate in transcription (33 -40) and since variations in transcription can modulate trait penetrance (7), we hypothesized that SMARCAL1 also modulates transcription and that penetrance of SMARCAL1 deficiency results from further alteration of gene expression.
To test these hypotheses, we explored the effect of deficiency of the human, Drosophila and mouse SMARCAL1 orthologs on gene expression and the interaction of such deficiency with environmental and genetic modifiers of transcription. We find that in humans, flies and mice, deficiency of the respective SMARCAL1 ortholog alters expression of many genes and that in flies and mice deficiency of the respective ortholog is insufficient to cause disease in the absence of additional environmental or genetic insults.
RESULTS

Deficiency of Marcal1 is insufficient for disease manifestations in Drosophila
To investigate whether deficiency of SMARCAL1 orthologs is sufficient to cause disease, we developed a Drosophila melanogaster model. Similar to human SMARCAL1, the only fly ortholog Marcal1 also encodes a DNA-specific ATPase (NP_608883.1, Marcal1) ( Fig. 1A and B) ; it shares 32% amino acid identity and 44% amino acid similarity with SMARCAL1 (24) . Like human SMARCAL1 and mouse Smarcal1 (25, (41) (42) (43) , Marcal1 is a nuclear protein and is highly expressed in the early embryo and developing tissues and gonads (Supplementary Material, Fig. S1 ).
By mobilizing P-element KG9850 and screening for deletions of the Marcal1 gene, we generated a loss-of-function Marcal1 mutant that lacked 679 bp extending from the middle of the first exon into the second intron (NM_135039.1:c. 673_1258delinsATGATGAAATAACAT-CATTATATCGATTAACACAG, p.G225MfsX3, Marcal1 del , Supplementary Material, Fig. S2A ). Marcal1 del/del flies did not express Marcal1 mRNA and protein (Supplementary Material, Fig. S2B and C), and surprisingly, like the unaffected individuals with biallelic SMARCAL1 mutations (20, 21) , the mutant flies exhibited no morphologic differences when compared with wild-type flies and had a normal lifespan at 208C.
Deficiency of murine Smarcal1 is insufficient to cause disease
To address whether the absence of disease in Marcal1-deficient flies was attributable to the absence of tissues such as bones, mammalian kidneys and T cells, we generated mice deficient for Smarcal1. Smarcal1 is the only SMARCAL1 ortholog in mouse and encodes a DNA-specific ATPase (NP_061287.2, Smarcal1) (Fig. 1C ) that has 72% amino acid identity and 78% amino acid similarity to the human SMARCAL1 (24) . Using standard homologous recombination knockout technology, we deleted the first two coding exons of Smarcal1 (NM_018817.2:c.172_989del, Smarcal1 del/del ). These exons include the replication protein A binding site, nuclear localization signal and the first HARP domain (Supplementary Material, Figs S3-S5); deletion of the HARP domains has been associated with defective annealing helicase activity and disease in humans (24, 44) . When maintained on a mixed 75% 129SvEv and 25% C57BL/6 background, the Smarcal1 del/del mice did not show developmental, growth or physical abnormalities or other signs of disease through 24 months (Supplementary Material, Fig. S6A -L) . Analysis of lymphatic tissues showed that Smarcal1 del/del mice had a reduction in their B-cell count but no T-cell deficiency (Supplementary Material, Fig. S6M -P) . Similarly, when the Smarcal1 del allele was backcrossed onto a C57BL/6 background, the Smarcal1 del/del mice did not show developmental, growth or physical abnormalities and had the same immunologic phenotype as the mice on the mixed background (data not shown). Therefore, like the incomplete penetrance reported for the two human families (20, 21) , deficiency of the respective SMARCAL1 ortholog in fruit flies and mice was insufficient to cause overt disease.
SMARCAL1 and Marcal1 bind open chromatin
To better understand the function of proteins encoded by SMARCAL1 orthologs in the nucleus, we analyzed the association of SMARCAL1 and Marcal1 with chromatin. We used immunofluorescence to localize HA-tagged SMARCAL1 and Marcal1 on polytene chromosomes from third instar fruit fly larvae. Both SMARCAL1 and Marcal1 co-localize with trimethyl-K4 histone H3 and acetylated histone H4, which are markers of transcriptionally active chromatin ( Fig. 2C-E) . The regions of increased adenine methylation also corresponded to accessible, transcriptionally active and early replicating chromatin ( Fig. 2F -H and J). In contrast, adenine methylation was decreased in regions enriched for trimethyl-K27 histone H3 (Fig. 2I ), a mark of inactive chromatin (46) . The enrichment for adenine methylation spanned transcribed regions and was preferentially enriched in promoter regions compared with the rest of the gene ( Fig. 2K and L) . To determine whether this preference for promoter regions might correlate with promoter proximal pausing or stalling of RNA polymerase II (RpII) (47), we compared our adenine methylation data with published RpII distribution in S2 cells (48) or Toll 10b embryos (49) . This showed that adenine methylation was enriched in genes bound by RpII regardless of whether RpII was stalled or active and was underrepresented in genes without RpII binding. In contrast, transcriptionally inactive polycomb targets (46) were 
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Human Molecular Genetics, 2012, Vol. 21, No. 11 Table S1 ). Thus, Marcal1 likely has a broader role in transcription than modulating promoter proximal pausing or stalling of RpII.
Marcal1 and SMARCAL1 genetically interact with transcriptional components
To obtain genetic evidence that Marcal1 and SMARCAL1 are involved in transcription, we conducted a screen in D. melanogaster for enhancers and suppressors of the wing vein phenotype induced by expressing Marcal1 or SMARCAL1 under the control of the UAS promoter and the tubulin-GAL4 or MS1096-GAL4 drivers, respectively (Supplementary Material, Table S2 ) (25) . We observed epistatic interactions with mutations of transcriptional regulators, including chromatin proteins, mediator complex members, RpII complex components and transcription initiation, elongation and termination factors (Supplementary Material, Table S2 and Fig. S9 ). Generally, but not always, loss-of-function mutations of transcriptional enhancers suppressed the wing vein phenotype, whereas loss-of-function mutations of transcriptional repressors enhanced the wing vein phenotype (Supplementary Material, Table S2 ).
SMARCAL1 deficiency alters gene expression in SIOD skin fibroblasts
To clarify whether the SMARCAL1 chromatin binding and its genetic interactions with transcriptional components were indicative of function, we checked whether deficiency of SMARCAL1 altered gene expression. Using the Affymetrix Human Genome U133 Plus 2.0 Array, RNA derived from dermal fibroblasts of two SIOD patients (SD8 and SD60) showed significantly (q-value , 0.05) altered expression of 5644 genes (log 2 median fold change of 20.255) ( Fig. 3A and B; Supplementary Material, Fig. S10A and Table S3 ). Of these, 632 had .2-fold higher expression and 766 genes had .2-fold lower expression. The gene ontology (GO) biologic process annotations enriched among these differentially expressed genes included cellular and molecular metabolic processes, programmed cell death, cell cycle, signaling pathways and stress response (Supplementary Material,  Tables S4 and S5) . Identification of the stress response was particularly intriguing since several patients with SMARCAL1 deficiency have developed severe migraine-like headaches, transient weakness and transient paraplegia during hot weather (C.F.B., unpublished data). To test whether SMARCAL1 modulated expression of heat shock genes, we heat-stressed skin fibroblasts from a control individual and three SIOD patients (SD31, SD120 and SD123) for 1 h at 438C. Using quantitative reverse-transcriptase PCR (qRT-PCR), we found that many heat stress response genes were significantly overor under-expressed in the SMARCAL1-deficient fibroblasts ( Table S6 ).
Marcal1 contributes to heat tolerance and modulates heat stress gene expression in Drosophila
Given the abnormal response to heat stress by SIOD patients and SMARCAL1-deficient skin fibroblasts, we hypothesized that heat stress modifies the penetrance of Marcal1 deficiency. To test this, we reared Marcal1 del/del and yellow white (yw) control flies at 20, 25 and 308C. Although no differences were noted at 208C, Marcal1 del/del embryos and flies were significantly less viable at 258C (,75% viability) and at 308C (,20% viability) than yw control flies ( Fig. 4A and B) . Also, compared with yw flies, Marcal1 del/del flies had abnormal expression of heat shock genes and proteins both at baseline and after 15 min at 378C (Supplementary Material, Fig. S12 ).
The Marcal1 del/del flies also laid smaller eggs than yw controls at 258C but not at 208C ( Fig. 4C and D) . At 208C, the mean (+SD) egg volume was 0.0116 + 0.0018 mm 3 for yw versus 0.0115 + 0.0015 mm 3 for Marcal1 del/del (n ¼ 100, P ¼ 0.56). In contrast, at 258C the mean (+SD) egg volume Heat map of the log 2 fold differences in RNA levels (q-value ,0.05) between control and SIOD patient (SD8 and SD60) skin fibroblasts. The RNA levels were measured using Affymetrix Human Genome U133 Plus 2.0 arrays and are the average of three biologic replicates. (B) Density plot showing the distribution of the log 2 fold differences in RNA levels (q-value ,0.05) between control and SIOD fibroblasts. (C) Volcano plot comparing the expression of stress genes in control and SIOD (SD31) skin fibroblast cell lines after 1 h incubation at 438C followed by 1 h incubation at 378C. The plot is derived from three biologic replicates.
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Human Molecular Genetics, 2012, Vol. 21, No. 11 del/del flies housed at 208C with those housed at 258C, using Affymetrix Drosophila Genome 2.0 Array. We found significant differences (q-value , 0.05) in the expression of 123 genes at 208C and of 148 genes at 258C; 81 genes were common in both groups. Furthermore, comparison of gene expression differences between yw and Marcal1 del/del ovaries at 20 and 258C showed a shift in the log 2 median fold change from 0.01 at 208C to 20.03 at 258C (Fig. 4E and F) . For both 20 and 258C, the GO biologic process annotations enriched among genes differentially expressed between yw and Marcal1 del/del ovaries included metabolic processes and response to stress (Supplementary Material, Tables S7-S9 and Fig. S10B ).
Smarcal1 contributes to heat tolerance and modulates heat stress gene expression in mice
To test whether heat stress modified penetrance in the Smarcal1 del/del mice, we housed the mice at 39.58C. All Smarcal1 del/del mice died within 6.5 h, whereas only 20% of wild-type (Smarcal1 +/+ ) mice died in 10 h (Fig. 4G) . We used Illumina Next Generation Sequencing to characterize the transcriptomes of livers from Smarcal1 del/del and Smarcal1 +/+ mice at an ambient temperature of 208C or following 1 h at 39.58C ( Fig. 4H and I (Fig. 4H and I ). The genes with altered expression mapped to multiple GO biologic process annotations, including cellular and molecular metabolic processes, gene expression, stress response and immune response (Supplementary Material, Tables S13 and S14, and Fig. S10C) .
To confirm the altered stress response identified in the liver transcriptome data, we used qRT-PCR to analyze heat shock gene expression in RNA isolated from the livers and brains of the 3 h heat-stressed Smarcal1 del/del and Smarcal1
mice. This confirmed dysregulated expression of heat shock genes in both tissues (Supplementary Material, Table S15 ).
RpII inhibition decreases proliferation in SMARCAL1-deficient human fibroblasts
Having found that SMARCAL1, Marcal1 and Smarcal1 modulate gene expression during the heat stress response and are needed for heat tolerance, we hypothesized that other environmental and genetic factors altering transcription also induce penetrance when SMARCAL1 orthologs are deficient. To test this, we incubated skin fibroblasts from a control individual and three SIOD patients (SD31, SD120 and SD123) for 48 h with 1 mg/ml of a-amanitin, a toxin that preferentially inhibits RpII (50, 51) . At this dose, SIOD fibroblasts proliferated significantly slower than control fibroblasts as measured by MTT assay and EdU incorporation by the Click-iT EdU assay (Fig. 5A) ; there was no difference in apoptosis or necrosis as judged by TUNEL assay and trypan blue staining (data not shown). Also, knockdown of the largest subunits of RpII, using shRNAs against POLR2A or POLR2B in SIOD fibroblasts, resulted in significantly decreased proliferation compared with a non-targeting shRNA or with knockdown of RpII components in control fibroblasts (Supplementary Material, Fig. S13A and B) . This interaction between RpII and SMARCAL1 did not result from protein -protein interactions since SMARCAL1 did not co-precipitate with RpII (data not shown). ). Comparing the hatching of these embryos with Marcal1 del/del and RpII heterozygous mutant embryos showed that these had a significantly reduced hatching rate at 208C (Fig. 5B ). This reduced hatching was not associated with increased apoptosis as measured by acridine orange staining or from altered protein -protein interactions between RpII215 and Marcal1 since Marcal1 did not co-precipitate with RpII215 (data not shown).
Besides reduced hatching, the introduction of a single mutant allele of RpII215 into the Marcal1 del/del background reduced the size of eggs relative to those of Marcal1 del/del and RpII215 heterozygous mutants (Fig. 5C) Tables S7 and S16) .
Reciprocally, the introduction of the biallelic deletion of Marcal1 into the background of the RpII215 4 mutation also increased the number of differentially expressed genes and the magnitude of the overall expression differences. Compari versus yw ovaries. The 378 differentially expressed genes mapped to many GO biologic process annotations, including cellular and metabolic processes and gene expression ( Fig. 5D and E and Supplementary Material, Tables S7 and S17).
RpII inhibition decreases proliferation in
Smarcal1-deficient mouse embryonic fibroblasts
Having observed the interactions of SMARCAL1 and Marcal1 with RpII, we asked whether the inhibition of RpII function had a similar effect in Smarcal1 del/del mouse embryonic fibroblasts (MEFs). When treated with 1 mg/ml a-amanitin, Smarcal1 del/ del MEFs proliferated significantly more slowly than Smarcal1 +/+ fibroblasts as measured by the MTT assay and EdU incorporation by the Click-iT EdU assay (Fig. 5F ). Also, they exhibited no difference in apoptosis or necrosis as judged by the TUNEL assay and trypan blue staining (data not shown). Furthermore, knockdown of the largest subunit of RpII, using siRNAs against Polr2a in Smarcal1 del/del MEFs, resulted in a significantly decreased proliferation rate compared with knockdown of Polr2a in Smarcal1 +/+ MEFs or with the treatment of Smarcal1 del/del MEFs with a non-targeting siRNA (Supplementary Material, Fig. S13C and D) .
RpII inhibition modifies the penetrance of Smarcal1 deficiency and partially recapitulates SIOD in Smarcal1-deficient mice Based on the preceding findings, we hypothesized that variations in gene expression are critical for expression of SIOD disease features. To test this in vivo, we injected Smarcal1 del/del and Smarcal1 +/+ mice with either carrier (PBS, phosphate buffered saline) or a-amanitin (0.1 mg/kg/ day) for 12 weeks. Although they did not develop T-cell deficiency (Supplementary Material, Fig. S14 ), the Smarcal1 del/del mice injected with a-amanitin developed features of SIOD that were not observed in a-amanitin-treated Smarcal1 +/+ mice or in PBS-treated Smarcal1 del/del and Smarcal1 +/+ mice (Fig. 6 ). First, they had length and weight growth restriction ( Fig. 6A -C) , and consistent with the growth restriction in SIOD, the mice had a disproportionately short spine ( Fig. 6D and E). Second, as reported for SIOD growth plates (23, 52) , the distal femur growth plates were hypocellular, and chondrocytes in the proliferation and hypertrophic zones formed less organized columns (Fig. 6F-N) . Finally, reminiscent of the early renal disease in SIOD, the treated Smarcal1 del/del mice developed albuminuria (Fig. 6O) .
DISCUSSION
We have shown that the proteins encoded by SMARCAL1 orthologs localize to transcriptionally active chromatin, modulate gene expression and have epistatic interactions with transcription factors. We also found that, similar to the lack of penetrance for biallelic SMARCAL1 mutations in humans, deficiency of the orthologs in fruit flies and mice is insufficient to cause disease in these organisms and that penetrance is associated with environmental or genetic insults that further modify gene expression. From these observations, we hypothesize that the annealing helicase function of SMARCAL1, Marcal1 or Smarcal1 maintains DNA topology to buffer variability in gene expression and thereby mitigates penetrance of pathologic traits arising from environmental and genetic insults (Fig. 7) .
As an annealing helicase, SMARCAL1 resolves ss-to-ds DNA transitions (26) . Such transitions occur during DNA replication, repair, recombination and transcription, and recent studies have shown that SMARCAL1 participates in the DNA stress response both at stalled replication forks and at double-strand DNA breaks repaired by recombination or end joining (28 -32) . However, since defects of DNA repair, replication and recombination have not been detected clinically in SIOD patients (53), we reasoned that, like many DNA repair enzymes (33) (34) (35) 37, 40, 54) , SMARCAL1 contributes to transcription and that its deficiency results in gene expression changes contributing to the pathophysiology of SIOD.
There are at least three non-exclusive models by which SMARCAL1 deficiency can alter gene expression. First, unrepaired DNA damage impedes RpII progression and impairs transcription (55) . Second, like ERCC6, SMARCAL1 could be part of the transcriptional complex and thus its deficiency directly affects RpII transcription (34) . Third, the DNA 
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Human Molecular Genetics, 2012, Vol. 21, No. 11 (53), (ii) SMARCAL1-deficient fibroblasts do not have delayed recovery of mRNA synthesis following exposure to ultraviolet light or illudin S (C.F.B., unpublished data), and (iii) the proliferation rate of SMARCAL1-deficient cells is not detectably perturbed relative to control cells even though the transition from G2 to M phase is slightly delayed (28, 31) . Evidence against the second proposed mechanism includes (i) failure of SMARCAL1 homologues to co-purify or co-immunoprecipitate with RpII and transcription complexes studied (56) (57) (58) and (ii) failure of RpII to co-purify or co-immunoprecipitate with SMARCAL1 or Marcal1. We hypothesize, therefore, that the SMARCAL1 orthologs influence gene expression through the maintenance of DNA structure. SMARCAL1 could modulate RpII transcription through the maintenance of the topology and helicity of duplex DNA. In prokaryotes, changes in DNA helicity cause gene expression to be enhanced, repressed or unchanged (59) , and the equilibrium between duplex DNA and strand opening modulates transcription factor binding and production of full-length RNA (60, 61) . Similarly, in eukaryotes, in vitro and in vivo studies of MYC expression show that transcription-induced supercoiling melts MYC far upstream element (FUSE) to enable binding by structure-sensitive regulatory proteins such as FUSEbinding protein (FBP) and FBP-interacting repressor (FIR) (62, 63) . Binding of FBP and FIR to FUSE modifies the rate of MYC promoter firing (62, 63) . Since negative supercoiling and positive supercoiling are generated upstream and downstream of the transcription bubbles (64, 65) , respectively, SMARCAL1, Marcal1 or Smarcal1 might contribute to the maintenance of DNA topology within and adjacent to transcribed regions. Deficiency of these orthologs would then alter gene expression as a consequence of the changes in DNA helicity or topology.
This model could also explain why, in contrast to transcription factors that bind conserved promoter elements, SMARCAL1, Marcal1 and Smarcal1 deficiencies do not consistently affect expression of homologous genes. Homologous genes in human, flies and mice frequently reside in different genomic neighborhoods or chromatin regions (66); therefore, the need for the SMARCAL1, Marcal1 and Smarcal1 to maintain duplex DNA around homologous genes might vary among species and thereby have differing effects on expression of homologous genes.
In summary, SMARCAL1 deficiency is insufficient to cause SIOD, but the addition of environmental and genetic insults affecting transcription does cause penetrance and partial recapitulation of SIOD in model organisms. At both the molecular and genetic levels, SMARCAL1 plays a role in modulating gene expression. One model for the penetrance of biallelic mutations of SMARCAL1 orthologs is shown in Figure 7 . In this model, SMARCAL1 orthologs modulate random fluctuations in gene expression and thereby potentiate or capacitate phenotypic changes induced by genetic or non-genetic insults, whereas the absence of the SMARCAL1 orthologs creates a chromatin environment permissive for such insults, pushing gene expression beyond a threshold of disease (Fig. 7) .
MATERIALS AND METHODS
Drosophila genetic studies
The y 1 ;P{SUPorP}Marcal1K G09850 /CyO flies, which have a P element insertion in the Drosophila homologue of SMARCAL1 (Marcal1) at 25B4, were obtained from the Bloomington However, when transcription is further compromised by environmental or genetic factors that cause gene expression to pass a threshold, the organism is unable to compensate and manifests a phenotype.
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Drosophila Stock Center (Bloomington, IN, USA). The loss-of-function mutant was obtained by imprecise P element excision (67) ; this deleted 679 bp nucleotides extending from the middle of the first exon into the second intron. The Marcal1 del flies were crossed to w 1118 flies for eight generations, and the specificity of the small egg phenotype to the homozygous deletion of Marcal1 in Marcal1 del/del flies was confirmed by failure of Df(2L)Excel7793, which has a breakpoint of 25B1;25B8, and Df(2L)Excel7795, which has a breakpoint of 25B3;25B9, to complement the Marcal1 del allele (68). For expression of tagged and untagged Marcal1 cDNAs, we generated five transgenic lines in w 1118 flies, using the pUAST and pUASP vectors: (i) UAST-Marcal1, (ii) UAST-HA-GFPMarcal1, (iii) UAST-SMARCAL1, (iv) UASP-HA-GFPMarcal1 and (v) UAST-N-Dam-Marcal1. All the other UAS lines, insertions and GAL4 lines used in this study were obtained from the Bloomington Drosophila Stock Center.
Using the SMARCAL1 and Marcal1 overexpression lines MS1096-GAL4/MS1096-GAL4; +/+; pUAST-SMARCAL1/ pUAST-SMARCAL1 and pUAST-Marcal1/CyO; tubulin-GAL4/TM3, Sb 1 the F1 genetic screen was carried out at 288C; all other crosses were performed at 208C unless indicated otherwise in the text. For the wing phenotype analysis, images from 10 wings for each genotype were acquired using a Zeiss Axiovert 200 microscope and scored by two independent readers. The reference for the enhancement or the suppression of the wing veins was the average of SMARCAL1 or Marcal1 overexpression flies crossed to w 1118 mutants of three different genetic backgrounds (Bloomington stocks 3605, 5905, 6326).
For egg hatching efficiency, three groups of 100 yw, Marcal1 del/del , RpII215 3 or 4 or 8 or K1 /FM7 and RpII215 3 or 4 or 8 or K1 /FM7;Marcal1 del/del embryos were collected at 208C. Hatching rates were calculated 45-48 h after egg deposition.
ATPase activity assay
The ATPase assay was performed with the purified Marcal1, SMARCAL1 and Smarcal1 proteins as previously described (25, 69) . See Supplementary Material for more details.
Immunofluorescence
Immunostaining of the Drosophila tissues and detection of human SMARCAL1 and mouse Smarcal1 were performed according to standard procedures as previously described (25, 41, 70, 71) . See Supplementary Material for more details.
High-dimensional (11-color) flow cytometry
Lymphoid tissues (spleen and thymus) from Smarcal1 del/del and Smarcal1 +/+ mice were harvested in RPMI-1640 medium containing 10% FCS. The tissues were pressed through a 70 mm nylon cell strainer, suspended in 10 ml of PBS and incubated with red cell lysis buffer (150 mM NH 4 CI) for 5 min. After washing with 10 volumes of PBS, single-cell suspensions were stained with fluorochromeconjugated anti-mouse B220, TCRab, CD4, CD8, CD44 and CD25 antibodies (BD Biosciences) (Supplementary Material, Table S18 ). 'Fluorescence-minus-one' controls were included to determine the level of non-specific staining and autofluorescence associated with subsets of cells in each fluorescence channel. Propidium iodide was added to all samples before data collection to identify dead cells. High-dimensional flow cytometry data were collected on an LSRII FACS instrument (BD Biosciences). The FLOWJO (TreeStar, San Carlos, CA, USA) software was used for fluorescence compensation and analysis.
Generation of Smarcal1 knock-out mice
Using standard homologous recombination knockout technology, we deleted the first two coding exons of Smarcal1 (NM_018817.2:c.172_989del) and generated Smarcal1 del/del ) were maintained in a temperature-and humidity-controlled incubator for 10 days. Surviving flies were tallied on day 10. To assess reproductive capacity, three groups of 100 yw and Marcal1 del/del embryos (300 in total for each genotype) were reared at different temperatures: group 1 was reared at 258C; group 2 was reared at 258C for the first 5 days and then shifted to 308C (25/308C); and group 3 was reared at 308C. Flies surviving to adulthood were counted. For assessing gene or protein expression, ten 1 -3-day-old female flies from each genotype (yw and Marcal1 del/del ) were heat-stressed at 378C in a water bath for 15, 30, 45 and 60 min with or without recovery for 1 h at room temperature. Mouse: Three groups of 4 -5 Smarcal1 +/+ and 4 -12 Smarcal1 del/del female mice at 3 -4 months of age were heat-stressed at 39.58C for 1, 3 and 10 h as previously described (72) . Human dermal fibroblasts: SIOD (SD31, SD120 and SD123) and control fibroblasts were heat-stressed for 1 h at 438C followed by 1 h of recovery at 378C as previously described (73) . and n ¼ 7 Smarcal1 +/+ ) or 0.1 mg/kg a-amanitin (Sigma) (n ¼ 9 Smarcal1 del/del and n ¼ 7 Smarcal1 +/+ ) diluted in PBS for 12 weeks. At the end of treatment, radiography was performed using the Faxitron X-ray cabinet. Human dermal fibroblasts: SIOD (SD31, SD120 and SD123) and control dermal fibroblasts were cultured in 96-well plates (3 × 10 3 cells/ well). After 24 h, the medium was supplemented with 0 or 1 mg/ml a-amanitin and the cells were analyzed 48 h later for cell proliferation and viability, using the MTT assay as previously described (74) . To measure proliferation with Click-iT EdU assay (Invitrogen), fibroblasts were cultured in the Lab-Tek 8 chambered cover glass system (7.5 × 10 3 cells/ well). After 24 h, the medium was supplemented with 0 or 1 mg/ml a-amanitin, and after another 24 h, 10 mM EdU was added to each well. EdU detection and analysis was performed after 24 h, using Alexa Fluor 555 and Zeiss Axiovert 200 microscope, according to the manufacturer's protocol. Murine embryonic fibroblasts: Sensitivity of Smarcal1 del/del and Smarcal1 +/+ fibroblasts to a-amanitin (0 and 1 mg/ml) was performed as described above for human fibroblasts.
RNA extraction and RT-PCR
RNA was extracted from the indicated tissue, using the RNeasy Mini Kit (Qiagen). cDNA synthesis was performed using SuperScript III First Strand Kit (Invitrogen) or qScript cDNA SuperMix (Quanta). Quantitative real-time RT-PCR was performed using the ABI 7500 Fast system, using the primers listed in Supplementary Material, Table S19 (see Supplementary Material for more details).
Urinary protein and creatinine measurement
Mouse urine samples were analyzed for total protein (Lowry Protein Assay Kit, Bio-Rad), creatinine (Creatinine Assay Kit, Cayman) or albumin (bromocresol green method). See Supplementary Material for more details.
Histopathology
Smarcal1
del/del and Smarcal1 +/+ mice tissues were fixed in 4% PFA in PBS, paraffin-embedded and cut into 5 mm sections according to standard protocols (75) . After H&E staining, tissues were analyzed using a Zeiss Axiovert 200 microscope. For distal femoral growth plate analysis, we counted all chondrocytes within the proliferative and hypertrophic zones and within 250 mm of the vertical midline.
Apoptotic analysis
Acridine orange staining for the detection of apoptotic cells in 20-23 h Drosophila embryos was performed as previously described (76). For human fibroblasts and MEFs, apoptotic cells were detected by TUNEL assay, using ApopTag Peroxidase In Situ Apoptosis Detection Kit (S7100, Chemicon).
RpII knock-down
Knock-down of the RpII genes encoding for the largest subunits of RpII in human fibroblasts and MEFs was carried out according to the Amaxa Biosystems optimized protocols (U-023 or A-023), using GFP-tagged shRNAs targeting POLR2A or POLR2B (SABiosciences) or Alexa Fluor 488-tagged siRNAs targeting Polr2a (Qiagen). See Supplementary Material for more details.
RNA sequencing and data analysis
For RNA sequencing, three samples of liver RNA were extracted from each group of 3 -4-month-old Smarcal1 del/del and Smarcal1 +/+ female mice at 208C and after 1 h at 39.58C. The RNA samples for each group were pooled, and RNA sequencing libraries were constructed and sequenced using the whole transcriptome shotgun sequencing procedure, as previously described (77-79). See Supplementary Material for details.
Microarray gene expression analyses
For gene expression array analysis of human cells, two samples of RNA were extracted from each of two SIODs (SD8 and SD60) and three of control skin fibroblast cell lines, labeled and hybridized to Affymetrix Human Genome U133 Plus 2.0 Arrays. For expression array analysis of Drosophila ovaries, three samples of RNA were extracted from Drosophila ovaries for each genotype at 20 and 258C, labeled and hybridized to Affymetrix Drosophila Genome 2.0 Array. See Supplementary Material for details.
GO analysis
GO analysis was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 (80,81) (See Supplementary Material for more details).
Dam analysis of Marcal1 binding
We performed DamID as previously described (46) (see Supplementary Material for more details).
Statistics
Data are presented as mean + SD unless otherwise stated. Comparisons were made using the two-tailed Student's t-test and Mann -Whitney U test. Differences were considered significant at a P-value of ,0.05 or a q-value of ,0.05. 
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